Agilon Health Inc (NYSE:AGL) finished Friday with a subtraction of -$0.69 to close at $17.76, a downside of -3.74 percent. An average of 2,052,380 shares of common stock have been traded in the last five days. There was a fall of -$0.67 in the past week, and it reached a new high 11 times over the past 12 months. The last 20 days have seen an average of 2,037,395 shares traded, while the 50-day average volume stands at 2,210,782.
AGL stock has decreased by -3.11% in the last month. The company shares reached their 1-month lowest point of $17.38 on 09/06/23. With the stock rallying to its 52-week high on 03/27/23, shares of the company touched a low of $15.00 and a high of $29.44 in 52 weeks. It has reached a new high 25 times so far this year and achieved 10.04% or $1.62 in price. In spite of this, the price is down -39.67% from the 52-week high.
Insider Transactions
AGL stock investors should be aware that Agilon Health Inc (AGL) stock had its last reported insider trading activity 17 days ago on Sep 13. In this transaction, the insider spent $337,455. Chief Markets Officer, Shaker Benjamin, disposed of 18,750 shares at a price of $18.05 on Sep 12. The insider now owns more than $338,481 worth of shares. Prior to that, Chief Accounting Officer Gertsch Timothy went on to Sale 26,250 shares at $18.61 each on Sep 11. An amount of $488,616 was transacted.
Valuation Metrics
Agilon Health Inc (AGL) stock’s beta is 0.94. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.96, the price-to-book (PB) ratio at 8.18.
Financial Health
The quick ratio of Agilon Health Inc for the three months ended June 29 was 1.50, and the current ratio was 1.50, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.05 and a total debt to equity ratio of 0.06 for the quarter ending June 29. Its gross profit as reported stood at $112.29 million compared to revenue of $2.71 billion.
Earnings Surprise
For the three-month period that ended June 29, Agilon Health Inc had $36.02 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$16.75 million in the quarter, while revenues were shrunk -23.28%. The analyst consensus anticipated Agilon Health Inc’s latest quarter earnings to come in at -$0.02 per share, but it turned out to be -$0.04, a -100.00% surprise. For the quarter, EBITDA amounted to -$24.31 million. Shareholders own equity worth $405.48 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Agilon Health Inc (AGL) price momentum. RSI 9-day as of the close on 29 September was 40.06%, suggesting the stock is Neutral, with historical volatility in this time frame at 27.46%.
As of today, AGL’s price is $18.37 -3.64% or -$0.67 from its 5-day moving average. AGL is currently trading +0.23% higher than its 20-day SMA and -31.35% lower than its 100-day SMA. However, the stock’s current price level is -1.11% below the SMA50 and +0.40% above the SMA200.
The stochastic %K and %D were 45.86% and 63.16%, respectively, and the average true range (ATR) was 0.73. With the 14-day stochastic at 17.01% and the average true range at 0.73, the RSI (14) stands at 44.52%. The stock has reached -0.13 on the 9-day MACD Oscillator while the 14-day reading was at -0.09.
Analyst Ratings
Evercore ISI launched coverage on Agilon Health Inc (NYSE: AGL) in its analyst report released on June 13, 2023. The firm assigned the stock an In-line rating. The consensus rating for Agilon Health Inc (AGL) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AGL, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 13 others rate it as a “buy”.
